Hart,

patience has its virtues, Roman was not built in a dAy and either is developing a drug from IND to passing phase 3 trials, it can easily take 20 years and RVX is at around 13 years with 2 more years to completion ,

If the assure trial post hoc analysis is proved not coincidence RVX will be a blockbuster and worth $5 to $10 billion,  I am willing to wait for that chance